Perry Shen

13.1k total citations · 2 hit papers
247 papers, 7.6k citations indexed

About

Perry Shen is a scholar working on Surgery, Emergency Medicine and Oncology. According to data from OpenAlex, Perry Shen has authored 247 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Surgery, 84 papers in Emergency Medicine and 82 papers in Oncology. Recurrent topics in Perry Shen's work include Intraperitoneal and Appendiceal Malignancies (119 papers), Appendicitis Diagnosis and Management (84 papers) and Ovarian cancer diagnosis and treatment (77 papers). Perry Shen is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (119 papers), Appendicitis Diagnosis and Management (84 papers) and Ovarian cancer diagnosis and treatment (77 papers). Perry Shen collaborates with scholars based in United States, China and Hong Kong. Perry Shen's co-authors include Edward A. Levine, Konstantinos I. Votanopoulos, John H. Stewart, Gregory B. Russell, Kim R. Geisinger, John H. Stewart, Paul H. Sugarbaker, Marcello Deraco, Olivier Gléhen and Richard P. McQuellon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Perry Shen

240 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

2004 899 citations Edward A. Levine, Perry Shen et al. profile →
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

2009 485 citations Edward A. Levine, Perry Shen et al. profile →

Peers

Countries citing papers authored by Perry Shen

Since Specialization

Citations

This map shows the geographic impact of Perry Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Shen more than expected).

Fields of papers citing papers by Perry Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Shen. The network helps show where Perry Shen may publish in the future.

Co-authorship network of co-authors of Perry Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Shen. A scholar is included among the top collaborators of Perry Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Shen. Perry Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate? 2025 ·Annals of Surgical Oncology ·Christopher W. Mangieri, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine	0
2	1310 PERIOPERATIVE CHEMOTHERAPY FOR CLINICAL STAGE IIIB GALLBLADDER CANCER: A REVIEW OF THE NATIONAL CANCER DATABASE 2024 ·Gastroenterology ·(unknown), (unknown), Clancy J. Clark, (unknown), Perry Shen	0
3	Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination 2024 ·Annals of Surgical Oncology ·Edward A. Levine, (unknown), Konstantinos I. Votanopoulos, Perry Shen, Greg Russell, Paul Mansfield, Keith F. Fournier, David L. Bartlett, John H. Stewart	1
4	Distance Traveled and Disparities in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy 2023 ·Annals of Surgical Oncology ·Ian Solsky, (unknown), (unknown), Gregory B. Russell, Kathleen C. Perry, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine	3
5	Endoscopic ultrasound‐guided gastrojejunostomy versus robotic gastrojejunostomy for unresectable malignant gastric outlet obstruction 2023 ·SHILAP Revista de lepidopterología ·Rishi Pawa, (unknown), Gregory B. Russell, Perry Shen, Swati Pawa	5
6	Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis 2022 ·HPB ·(unknown), Eliza W. Beal, George A. Poultsides, Kamran Idrees, Ryan C. Fields, Sharon M. Weber, Charles R. Scoggins, Perry Shen, Christopher L. Wolfgang, Shishir K. Maithel, Timothy M. Pawlik	7
7	Using Machine Learning to Preoperatively Stratify Prognosis among Patients with Gallbladder Cancer: A Multi-Institutional Analysis 2022 ·HPB ·(unknown), Eliza W. Beal, (unknown), Kamran Idrees, Ryan C. Fields, (unknown), Charles R. Scoggins, Perry Shen, Ioannis Hatzaras, (unknown), (unknown)	1
8	Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study 2021 ·Clinical Cancer Research ·Steven D. Forsythe, Richard A. Erali, Shyama Sasikumar, (unknown), (unknown), Ralph B. D’Agostino, Lance D. Miller, Perry Shen, Edward A. Levine, Shay Söker, Konstantinos I. Votanopoulos	50
9	Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium 2020 ·Journal of Surgical Oncology ·Kota Sahara, Diamantis I. Tsilimigras, Shishir K. Maithel, Daniel E. Abbott, George A. Poultsides, Ioannis Hatzaras, Ryan C. Fields, Matthew J. Weiss, Charles R. Scoggins, Chelsea A. Isom, Kamran Idrees, Perry Shen, Itaru Endo, Timothy M. Pawlik	26
10	Treatment patterns and outcomes in resected pancreatic cancers: Frequent deviations from standard of care 2020 ·HPB ·Omeed Moaven, (unknown), Georgina Russell, Christopher W. Mangieri, Russell Howerton, Konstantinos I. Votanopoulos, Erica Levine, Perry Shen	1
11	Analysis of recurrence after the resection of pancreatic neuroendocrine tumors 2018 ·Journal of Surgical Oncology ·Konstantinos Chouliaras, Naeem A. Newman, (unknown), Katrina Swett, Edward A. Levine, Jonathan G. Sham, Gary N. Mann, Perry Shen	15
12	Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy 2017 ·Journal of Surgical Oncology ·Ioannis T. Konstantinidis, Edward A. Levine, Konstantinos Chouliaras, Gregory B. Russell, Perry Shen, Konstantinos I. Votanopoulos	18
13	Proposal for a new t-stage classification system for distal cholangiocarcinoma: A 10-institution study from the U.S. extrahepatic biliary malignancy consortium 2016 ·HPB ·Lauren M. Postlewait, (unknown), (unknown), Kamran Idrees, (unknown), (unknown), (unknown), Perry Shen, (unknown), Ioannis Hatzaras, Shishir K. Maithel	1
14	Rates and patterns of recurrence after curative intent resection for gallbladder cancer: A multi-institution analysis from the us extrahepatic biliary malignancy consortium 2016 ·HPB ·Georgios Antonios Margonis, George A. Poultsides, Kamran Idrees, (unknown), (unknown), (unknown), Perry Shen, (unknown), Ioannis Hatzaras, Shishir K. Maithel, Timothy M. Pawlik	5
15	Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer 2013 ·Annals of Surgical Oncology ·Konstantinos I. Votanopoulos, Katrina Swett, Aaron U. Blackham, Chukwuemeka Ihemelandu, Perry Shen, John H. Stewart, Edward A. Levine	22
16	Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC) 2012 ·Journal of Surgical Oncology ·(unknown), Richard P. McQuellon, Gregory B. Russell, Craig S. Cashwell, Perry Shen, John H. Stewart, Edward A. Levine	22
17	Surgical Quality and Nodal Ultrastaging Is Associated With Long-Term Disease-Free Survival in Early Colorectal Cancer 2010 ·Annals of Surgery ·Anton J. Bilchik, Aviram Nissan, Zev A. Wainberg, Perry Shen, Martin D. McCarter, Mladjan Protić, Robin Howard, David Elashoff, (unknown), George E. Peoples, Alexander Stojadinovic	53
18	Pleuropulmonary Involvement in Pseudomyxoma Peritonei 2007 ·American Journal of Clinical Pathology ·Kim R. Geisinger, Edward A. Levine, Perry Shen, Robert F. Bradley	30
19	Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy 2006 ·Annals of Surgical Oncology ·John H. Stewart, Perry Shen, Gregory B. Russell, Robert F. Bradley, Jonathan Hundley, Brian Loggie, Kim R. Geisinger, Edward A. Levine	132
20	Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast 2002 ·The American Journal of Surgery ·Stephen A. Shiver, Andrew J. Creager, Kim R. Geisinger, Nancy D. Perrier, Perry Shen, Edward A. Levine	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact